Allergan

This weekend's Barron's cover story takes a look at whether the hot IPO market is a bubble. Other featured articles review Dividend Aristocrats on a roll and offer the results from a survey of tech CIOs. Also, the prospects for a pharmaceutical merger, a best-in-class cruise line operator...

This weekend's Barron's shows why one key analyst has a contrarian view on the direction that health care costs are headed. Other featured articles examine the prospects for pharmaceutical company facing new competition and an apparel retailer with a brand that is on a roll. Also...

Insider buying can be an encouraging signal for potential investors. Several health care companies saw notable insider buying this past week. Insiders included a company founder and a renowned former CEO. Conventional wisdom says that insiders and 10-percent owners really only buy shares...

Apple Inc. (NASDAQ: AAPL), Uber and Nike Inc (NYSE: NKE) were among nearly 100 multinational corporations exposed Monday to have developed shell companies and offshore accounts in alleged tax avoidance schemes. The Paradise Papers, 13.4 million files obtained by German newspaper Süddeutsche...

This weekend's Barron's cover story takes a look at the likely winners arising from a new breed of super semiconductors. The prospects for a media giant, a do-it-yourself moving company and a German chemicals maker are also examined. This issue also includes a special report on Barron's 12th...

Jim Cramer is no fan of Mylan NV (NASDAQ: MYL) and how it handled the EpiPen controversy. Cramer ranted on Thursday's "Squawk Box" that EpiPen has to be a "much bigger source" of Mylan's profit than the company is letting on and he would like to see the company's...

Allergan plc Ordinary Shares (NYSE: AGN)'s acquisition of Tobira Therapeutics Inc (NASDAQ: TBRA) has some analysts wondering: if Allergan is willing to pay a massive 500 percent premium for Tobira, then what could possibly come next? Barrons cited Kevin Kedra, an analyst at Gabelli, who...

Allergan plc Ordinary Shares (NYSE: AGN) paid a hefty premium of 159 percent to acquire Vitae Pharmaceuticals Inc (NASDAQ: VTAE) last week, but that figure pales in comparison to the premium attached to its acquisition of Tobira Therapeutics Inc (NASDAQ: TBRA). Allergan will pay $533 million in...

Brenton Saunders is the CEO and president of Allergan plc Ordinary Shares (NYSE: AGN), and on Tuesday, he clarified what he believes to be the core components of an already existing "social contract" with stakeholders. In a blog post, Saunders stated he understands the recent public outcry against...

Oracle Corporation (NYSE: ORCL) announced a massive $14 billion corporate bond sale this week. The company plans on using the proceeds for stock repurchases, dividend payments, debt refinancing and other budget items. While certainly impressive, Oracle’s sale is not even one of the five...

The billionaire investor confirmed through his Twitter account that he has acquired a "large position" in Allergan plc Ordinary Shares (NYSE: AGN). Shares of Allergan were trading higher by more than 2.5 percent after Tuesday's opening bell. Icahn also said in a statement is he is...

Allergan plc (NYSE: AGN) announced on Thursday it has entered into an agreement to acquire Topokine Therapeutics, a privately held, clinical-stage biotechnology that focuses on the development of topical medicines for fat reduction. As part of the agreement, Allergan made an up-font payment of $85...

Featured stories this weekend in Barron's ponder the prospects for a Detroit automaker, a semiconductor giant and the inventor of Bubble Wrap. This issue also has a look at a jet propulsion company and a pair of small cap banks. Other articles discuss the state of the U.S. auto industry, the top...